|
S.No. |
Name |
Year |
Country/city |
Title of delivered lecture & Date |
Information of the speakers and Profile link |
|
1. |
Professor Yidong Bai |
2023
|
Department of cell systems & anatomy UT Health San Antonio , TX, United States |
The implication of mitochondria in aging (15.02.2023) |
Prof. Yidong Bai's lab is interested in a comprehensive understanding of mitochondrial function at the molecular, cellular, tissue, and animal levels; in a wide range of conditions, such as diabetes, neurodegenerative diseases, cancers, and aging. The central theme in the laboratory is to investigate the regulatory mechanisms working in mitochondria and the role of mitochondria in regulating various cellular pathways. He has trained several postdoctoral fellows and PhD students and published more than 100 articles in peer reviewed journals. His research is well supported by several research grants including from National Institute of Health, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute of Aging. |
|
2. |
Dr. Ganesh V. Halade, Ph.D |
2021
|
Associate Professor, Department of Medicine, Division of Cardiovascular Sciences, University of South Florida (USF), Tampa, FL United States |
Inflammation-Resolution Signaling in Heart Failure (16.09.2021) |
About the speaker:Dr.Halade is a cardiovascular research scientist working on how unresolved chronic inflammation and immune responsive metabolic dysregulation contributes to ischemic and non-ischemic heart failure. His laboratory is working on different aspects of cardiovascular research including 1) study of heart failure etiology 2) mediators that are involved in cardiac repair after heart attack; 3) inflammation-resolution processes in heart failure. He has published more than 70 research articles in reputed high impact journals and has received several awards for his research including Barbara Bowmen award for excellence in postdoctoral studies and Sudhir Gupta Young Investigator from Association of Scientists of Indian Origin in America. He is very well funded with grants from NIH and AHA and actively involved in teaching and mentoring of research students at university of south Florida. |
|
3. |
Prof. Russel J. Reiter, PhD |
2021
|
Department of Cell Systems & Anatomy The University of Texas Health Science Center at San Antonio, TX, United States |
Melatonin as a Treatment for COVID-19 Pathophysiology (12.08.2021) |
About the speaker: Dr. Reiter's research interests relate to free radical aspects of disease processes and aging, and their function in apoptosis, necrosis and neuronal degeneration. Besides, Dr. Reiter's group is investigating the free radical scavenging and antioxidant properties of pineal indoleamines, most notably melatonin. The investigations include the mechanisms of interaction of melatonin with free radicals and the resulting products. He has trained 25 Ph.D. students and 144 postdoctoral fellows. Dr. Reiter has received numerous awards for his research including the A. Ross McIntyre Gold Metal (USA), US Senior Scientist Award (Germany), LizoniLincee Award (Italy), Inaugural Aaron B. Lerner Pioneer Award (USA), Chulabhorn Royal Academy Medal (Thailand). He has published numerous research papers, reviews and chapters and has written or edited 25 books. Dr. Reiter is designated a Highly Cited Scientist (top 0.1%) and in 2014 he was named one of the World's Most Influential Scientific Minds. |
|
4. |
Prof. Edward Prochownik, MD, PhD |
2021
|
Director of Oncology Research, UPMC Children's Hospital of Pittsburgh Professor of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine Pittsburgh, PA, United States |
Drivers of Pediatric Liver Cancer and its Biological Diversity (30.07.2021) |
About the speaker: Dr. Prochownik's research is focused on understanding molecular and biochemical mechanisms of cancers resulting from the deregulated expression of the c-Myconcoprotein (i.e. hepatoblastoma and hepatocellular carcinoma). He has published more than 170 peer reviewed articles covering different aspect of cancer metabolism and well supported by research funding from NIH. He has mentored several MD, PhD students and postdoctoral fellows and has received several awards in his career including University of Pittsburgh Pitt innovator award. He also serves as an editorial board member of various scientific journals. |
|
5. |
Prof. Arlan Richardson, Ph.D. |
2021
|
Director, Oklahoma Nathan Shock Aging Center Professor of Biochemistry & Molecular Biology University of Oklahoma Health Science Center, Oklahoma City, OK, United States |
Role of Inflammaging in Aging and Age-Related Diseases (15.07.2021) |
About the speaker : Dr. Richardson's research is focused on understanding the molecular mechanisms of aging and age related diseases. He has mentored more than 50 Ph.D. graduate students, postdoctoral fellows, and junior faculty and is the author of more than 300 peer-reviewed scientific publications. He is the receipt of several prestigious awards for his outstanding contribution in aging research including Nathan Shock Award, Robert W. Kleemeier Award, Harman Research Award, Irving Wright Award of Distinction. His leadership roles include serving as president of both the Gerontological Society of America and the American Aging Association. He also served in Board of Scientific Counselors at the National Institute on Aging and the National Advisory Council on Aging. |
|
6. |
Prof. Magdy Abdelal |
2018
|
Chemistry department, faculty of science. Mansoura University, Mansoura, Egypt. |
“Utilization of polymeric nanomaterials in medicial application” (16.12.2018) |
Prof. Magdy Abdelal is the Head of the Organic Chemistry Division; Director of the "Research and Development of Plastic and Rubber Industry Unit", Mansoura University, 2016; and Steering Committee Member of the Support Center for Small and Medium Industries, Mansoura University. He was a visiting professor at KAUST-Cornell Center for Energy and Sustainability, Cornell University, NY, USA for two months in 2015. Besides, he has cross-cooperation with many institutions such as LNF/INFN, Italy; NIMC and Toyohashi University of Technology, Japan and most institutions in Egypt. He attended and co- organized many national and international conferences. He has published over 50 papers in reputed ISI recognized journals and served as a reviewer for many international journals. His research focuses on polymers and their nano-composites in wastewater treatment, energy and sustainability-related polymeric nanomaterials, polymer recycling, pharmaceutical and biomedical applications and as templates for photonanocatalysts preparation. Link: https://alliedacademies.com/profile/Prof%20Magdy%20Y%20Abdelaal |
|
7. |
Dr. Ashutosh K Mangalam |
2018 |
University of IOWA, IA, USA. |
Therapeutic potential of gut Microbiota (16.12.2018) |
The major goal of Dr. Mangalam’s research is to develop better treatment options to cure multiple sclerosis (MS). To achieve this goal, the research program focuses on three major interconnected themes: i) to understand the role of gut microbiome and metabolome in the etiopathogenesis of MS; ii) test therapeutic efficacy of human gut derived bacteria as drug (BRUG) in animal models of MS; and iii) utilize transgenic mice expressing MS susceptible and resistant HLA class II molecules (HLA transgenic mice) to understand the mechanisms of disease pathogenesis. |
|
8. |
Dr. Rakesh Kumar |
2016 |
George Washington university, Washington, DC |
“Targeting Chromatin Remodeling Factors and Bromo-domain Proteins in Cancer” (18.10.2016) |
am interested in understanding of the role of cellular signaling in the regulation of selective cancer phenotypes in cancer progression with a particular focus on the chromatin and cytoskeleton remodelling in the context of gene expression and post-translational modifications. The laboratory is pursuing the hypothesis that human cancer, being a polygenic heterogeneous disease, often involves simultaneous dysregulation of multiple pathways to provide complementary dysregulated functions to promote cancer progression. To achieve these goals, we have selected prototypic molecules which are at the crossroads of oncogenesis, cell survival, inflammation, and genome integrity, and using tools from molecular biology, genetics, proteomics, epigenetics, bioinformatics, and platform based technologies. A better understanding of these questions will allow us to continue to make conceptual advances, build new molecular pathways, and develop the next generation of cancer therapeutic targets, while training students and postdoctoral fellows for their independent career in life sciences. |
|
9. |
Dr. Anuja Bhargava |
2016 |
UNICEF, Lucknow. |
Visiting Guest (15.01.2016) |
Link: https://www.linkedin.com/in/anuja-bhargava-22268064/?originalSubdomain=in |
|
10. |
Dr. Nishigandha Nyak |
2015 |
Half line Institute for training research & testing, Mumbai |
Visiting Guest (30.11.2015) |
Dr. Nishigandha Naik is working as a Director (additional charge) at the Haffkine Institute for Training, Research and Testing (HITRT), Mumbai and is the Head of the Dept. of Biochemistry and Dept. of Toxicology. She has more than twenty eight years of research work experience that includes academia as well as industry. Her work is in the field of cancer cell biology, imaging and pre-clinical drug discovery. Her basic research is focused on cell motility related signal transduction events and development of therapeutic approaches for cancer, especially chronic myeloid leukemia, breast cancer, glioblastoma and neural stem cells. |
|
11. |
Dr. Yasuo Tscuchiya |
2015
|
Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Japan
|
Proteomics in gall bladder cancer (07.11.2015) "Etiologic study on gallbladder cancer in Chile" by Dr Tsuchiya
|
https://pubmed.ncbi.nlm.nih.gov/?term=Yasuo+Tsuchiya&sort=date
|